Pratschke Johann, Paz Dustin, Wilhelm Markus J, Laskowski Igor, Kofla Gregorz, Vergopoulos Athanasios, MacKenzie Harald J, Tullius Stefan G, Neuhaus Peter, Hancock Wayne W, Volk Hans-Dieter, Tilney Nicholas L
Department of Surgery, Humboldt University, Charité-Virchow Clinic, Berlin, Germany. Johann.
Transplantation. 2004 Jan 15;77(1):43-8. doi: 10.1097/01.TP.0000092003.02115.95.
Marginal donor organs are used increasingly for transplantation. To define the influences of donor hypertension, we compared the behavior of kidney allografts from hypertensive and normotensive donors in an established rat model of chronic rejection.
Donor hypertension was induced by partial occlusion of the right renal artery with a silver clip. After 10 weeks, the left kidney was removed and transplanted. Normotensive animals served as controls. All recipients were treated with a low dose of cyclosporine for 10 days (1.5 mg/kg). Blood pressure and proteinuria were determined weekly four times after transplantation. To examine the effects of donor hypertension on late events, grafts (n=6/time point) were examined morphologically and by quantitative reverse transcriptase-polymerase chain reaction analysis at serial intervals.
Recipients of kidneys from hypertensive donors developed systemic hypertension in contrast with normotensive controls (P<0.05). Allografts from hypertensive animals showed accelerated deterioration in structure and function after transplantation. Proteinuria became significantly elevated as early as 6 weeks (P<0.05) compared with controls and increased progressively thereafter (P<0.005). Grafts from hypertensive donors, histologically normal at the time of engraftment, developed significant morphologic deterioration after 12 weeks (P<0.01). Changes in allografts from normotensive donors remained minor. mRNA of proinflammatory mediators in hypertensive donor grafts (P<0.01) was up-regulated before transplantation and increased progressively over time (P<0.01).
Donor hypertension intensifies the chronic injury associated with allogeneic kidney transplantation in the rat model used. This condition also leads to induction of recipient hypertension and may be a more important risk factor for chronic graft dysfunction than previously appreciated.
边缘供体器官越来越多地用于移植。为了确定供体高血压的影响,我们在已建立的慢性排斥大鼠模型中比较了来自高血压供体和正常血压供体的肾移植行为。
通过用银夹部分结扎右肾动脉诱导供体高血压。10周后,切除左肾并进行移植。正常血压动物作为对照。所有受体均接受低剂量环孢素治疗10天(1.5mg/kg)。移植后每周测定4次血压和蛋白尿。为了检查供体高血压对晚期事件的影响,在连续间隔时间对移植物(每个时间点n = 6)进行形态学检查和定量逆转录酶-聚合酶链反应分析。
与正常血压对照组相比,来自高血压供体的肾脏受体出现全身性高血压(P <0.05)。来自高血压动物的同种异体移植物在移植后结构和功能加速恶化。与对照组相比,蛋白尿早在6周时就显著升高(P <0.05),此后逐渐增加(P <0.005)。来自高血压供体的移植物在植入时组织学正常,12周后出现明显的形态学恶化(P <0.01)。来自正常血压供体的同种异体移植物变化较小。高血压供体移植物中促炎介质的mRNA在移植前上调(P <0.01),并随时间逐渐增加(P <0.01)。
在所用大鼠模型中,供体高血压加剧了与同种异体肾移植相关的慢性损伤。这种情况还导致受体高血压的诱导,并且可能是比先前认识到的更重要的慢性移植物功能障碍风险因素。